In main multivariate analysis adjusted for cancer stage and family history of venous thromboembolism (Table 2), we confirmed an odds ratio for VTE of 7.04 (95% CI, 2.01–24.63, p = 0.002) due to FVL mutation in cancer patients. The gene discussed is F5; the disease is venous thromboembolism.